INTERNATIONAL PATENT: JIANGSU HENGRUI PHARMACEUTICALS CO., LTD., 江苏恒瑞医药股份有限公司 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION COMPRISING IL-36R/IL-23-BINDING PROTEIN AND USE THEREOF"

GENEVA, March 2 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (No. 7 Kunlunshan Road, Economic And Technological Development Zone,Lianyungang, Jiangsu 222047), 江苏恒瑞医药股份有限公司 (中国江苏省连云港市经济技术开发区昆仑山路7号) filed a patent application (PCT/CN2025/115804) for "PHARMACEUTICAL COMPOSITION COMPRISING IL-36R/IL-23-BINDING PROTEIN AND USE THEREOF" on Aug 20, 2025. With publication no. WO/2026/041035, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under th...